Frontiers in Pharmacology | Pharmacogenetics and Pharmacogenomics

Systematic Review

Accepted on 20 Jun 2025

Polymorphisms in CYP3A5, CYP3A4, and ABCB1 Genes: Implications for Calcineurin Inhibitors Therapy in Hematopoietic Cell Transplantation Recipients-A Systematic Review

in Pharmacogenetics and Pharmacogenomics

Luiz Carlos da Costa-Junior
Daniely Regina Freitas-Alves
Amanda Melo Leite Leão
Hayra de Andrade Vieira Monterio
Rita de Cássia Barbosa da Silva Tavares
Maria Claudia Rodrigues Moreira
Marília Berlofa Visacri
Teresa de Souza Fernandez
Paulo Caleb J L Santos

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1569353

Original Research

Accepted on 19 Jun 2025

Exploring Biomarkers for Noise-Induced Hearing Loss through Mitochondrial DNA Methylation Analysis

in Pharmacogenetics and Pharmacogenomics

Dianpeng Wang
Caiping Li
Liuwei Shi
Dafeng Lin
Shaofan Weng
Xiangli Yang
Peimao Li
Zhimin Zhang
Wen Zhang
Yan Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561791

399 views

Systematic Review

Published on 19 Jun 2025

CYP2C19 variability and clinical outcomes of clopidogrel, proton pump inhibitors, and voriconazole in Southeast Asia: a systematic review and meta-analysis

in Pharmacogenetics and Pharmacogenomics

Harri Hardi
Agian Jeffilano Barinda
Liganda Endo Mahata
Zahra Fitrianti

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572886

375 views

Systematic Review

Accepted on 14 Jun 2025

Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: A systematic review and meta-analysis

in Pharmacogenetics and Pharmacogenomics

Ling Yin Fritz Wong
Alastair G. Sutcliffe
Carmen Lok Tung Ho
Yan Lu
Carrie L. Williams
Faiza Afzal
Mitana Purkayastha

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1568320

271 views

Review

Accepted on 13 Jun 2025

Global Variation in Antibiotic Prescribing Guidelines and the implications for decreasing AMR in the future

in Pharmacogenetics and Pharmacogenomics

Emmama Jamil
Zikria Saleem
Brian Godman
Matti Ullah
Afreenish Hassan
Abdul Haseeb
Johanna Catharina Meyer
Muhammad Usman Qamar
Safa Almarzoky Abuhussain

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1600787

173 views

Original Research

Published on 13 Jun 2025

Hsa_circ_0002238 promotes the malignant behavior of colorectal cancer

in Pharmacogenetics and Pharmacogenomics

Lin-Ting Zhang
Yuejia Zhou
Tiantian Wang
Boran Chen
Zhigao Cai
Shubin Wang
Gangling Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1541820

281 views

Original Research

Published on 04 Jun 2025

Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study

in Pharmacogenetics and Pharmacogenomics

Sireen Abdul Rahim Shilbayeh
Naglaa F. Khedr
Mohammad A. Alshabeeb
Abdulmonem Ali Alsaleh
Abdalrhman Hamdan Alanizi
Omnia A. Abd El-Baset
Rehab H. Werida

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604473

779 views

Original Research

Published on 03 Jun 2025

Exosomal miR-24-3p mediates myoblast-macrophage crosstalk to promote abdominal muscle repair

in Pharmacogenetics and Pharmacogenomics

Yuchen Liu
Zhenyu Zou
Jinxin Cao
Tong Zhu
Yilin Zhu
Yingmo Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604776

614 views

Brief Research Report

Published on 23 May 2025

Dynamic star allele definitions in Pharmacogenomics: impact on diplotype calls, Phenotype predictions and statin therapy recommendations

in Pharmacogenetics and Pharmacogenomics

Sven van der Maas
Simon Denil
Brigitte Maes
Gökhan Ertaylan
Pieter-Jan Volders

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584658

778 views

Original Research

Published on 22 May 2025

Biological and prognostic insights into the prostaglandin D2 signaling axis in lung adenocarcinoma

in Pharmacogenetics and Pharmacogenomics

Qiang Liu
Huiguo Chen
Dongfang Tang
Huibiao Zhang
Shaogeng Chen
Yiran Meng
Boying Zheng
Fei Liu
Jing Zhou
Wen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562261

1,219 views

Brief Research Report

Published on 22 May 2025

Implementation and integration of a multidisciplinary pharmacogenomics service in an underserved integrated behavioral health clinic

in Pharmacogenetics and Pharmacogenomics

Bader M. Alghamdi
Sara Rogers
Susan Roberman
Meredith Williamson
Ladan Panahi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594032

807 views

Case Report

Published on 21 May 2025

The role of endoplasmic reticulum aminopeptidase ERAP2 pathogenic mutation rs1363907 in amoxicillin clavulanate-induced liver injury: a special case report

in Pharmacogenetics and Pharmacogenomics

Yan Zhan
Jin-Mao Liao
Ling Ye
Long Zhang
Zheng Zhang
Ji-Ye Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564124

826 views

Original Research

Published on 20 May 2025

ARID1A deficiency attenuates the response to EGFR-TKI treatment in lung adenocarcinoma

in Pharmacogenetics and Pharmacogenomics

Fangfang Yang
Helei Hou
Guanqun Wang
Guangming Fu
Xingfa Huo
Xueqin Duan
Na Zhou
Xiaochun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1582005

760 views

Original Research

Published on 13 May 2025

Impact of CYP3A5 1* and 3* single nucleotide variants on tacrolimus pharmacokinetics and graft rejection risk in pediatric kidney transplant patients

in Pharmacogenetics and Pharmacogenomics

Lesly Yanira Xajil-Ramos
Jesús Alonso Gándara-Mireles
Rodrigo José Vargas Rosales
Oscar Kevin Sánchez García
Andrea Mariela Ruano Toledo
Amy Kateleen Aldana de la Cruz
Ismael Lares-Asseff
Leslie Patrón-Romero
Horacio Almanza-Reyes
Randall Lou-Meda

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592134

1,242 views

Case Report

Published on 13 May 2025

Primary hyperoxaluria type I diagnosed after a kidney transplant presenting with subcutaneous calcification: a case report of sodium thiosulfate treatment

in Pharmacogenetics and Pharmacogenomics

Min Wu
Jing Lu
Yu-Jia Wang
Yong-Qi Li
Qing Wei
Yu-Xiang Gong
Ri-Ning Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1485024

796 views

Original Research

Published on 01 May 2025

Unveiling the heritability of selected unexplored pharmacogenetic markers in the Saudi population

in Pharmacogenetics and Pharmacogenomics

Mohammad A. Alshabeeb
Deemah Alwadaani
Sireen A. R. Shilbayeh
Fatemah A. Alherz
Ali Alghubayshi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559399

2,196 views